Stock Information
Cytokinetics Inc (CYTK)
Ticker Symbol: CYTK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $9,499.55 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -7.2226
Revenue (TTM): $0.51 M
Dividend Yield: N/A%
ROE: -131.19%
Latest News
-
Cytokinetics (CYTK) Q2 2026 Earnings Call Transcript
Thu, Aug 13, 2026 10:32 PM
-
Barclays Maintains Overweight on Cytokinetics, Raises Price Target to $110
Thu, Aug 13, 2026 2:09 PM
-
JP Morgan Maintains Overweight on Cytokinetics, Raises Price Target to $103
Thu, Aug 13, 2026 11:04 AM
-
Cytokinetics Files Delaware U.S. District Court Claim Against Bristol-Myers Squibb And MyoKardia Seeking Judgment That CYTK Isn't Infringing U.S. Patent No. 12,616,697 And That The ’697 Patent Claims Are Invalid
Thu, Aug 13, 2026 9:35 AM
-
Truist Securities Maintains Buy on Cytokinetics, Raises Price Target to $112
Mon, Aug 10, 2026 1:45 PM
-
Cytokinetics (CYTK) Stock Looks Near Fair Value Despite UK MYQORZO Approval
Sat, Aug 8, 2026 11:10 AM
Key Financials
Financial data not available
